BUSINESS

J&J Hit With $8 Billion Jury Award Over Antipsychotic Drug – The Wall Street Journal

J&J Hit With $8 Billion Jury Award Over Antipsychotic Drug  The Wall Street JournalJury says J&J must pay $8 billion in case over male breast growth linked to Risperdal  ReutersJury says J&J must pay $8 billion in case over male breast growth linked to Risperdal  msnNOWPhila. Jury Returns $8 Billion Verdict Against Johnson & Johnson Over Risperdal | The Legal Intelligencer  Law.comJohnson & Johnson hit with $8bn court order over antipsychotic drug  Financial TimesView full coverage on Google News

Share to the world: